Regueiro MD - Search Results

1

White Paper AGA: The Impact of Mental and Psychosocial Factors on the Care of Patients With Inflammatory Bowel Disease.

Szigethy EM, Allen JI, Reiss M, Cohen W, Perera LP, Brillstein L, Cross RK, Schwartz DA, Kosinski LR, Colton JB, LaRusso E, Atreja A, Regueiro MD. Szigethy EM, et al. Among authors: regueiro md. Clin Gastroenterol Hepatol. 2017 Jul;15(7):986-997. doi: 10.1016/j.cgh.2017.02.037. Epub 2017 Mar 12. Clin Gastroenterol Hepatol. 2017. PMID: 28300693 Review.

2

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.

Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Regueiro M, et al. Am J Gastroenterol. 2003 Aug;98(8):1821-6. doi: 10.1111/j.1572-0241.2003.07581.x. Am J Gastroenterol. 2003. PMID: 12907338

3

Metabolic bone disease in inflammatory bowel disease.

Harpavat M, Keljo DJ, Regueiro MD. Harpavat M, et al. Among authors: regueiro md. J Clin Gastroenterol. 2004 Mar;38(3):218-24. doi: 10.1097/00004836-200403000-00005. J Clin Gastroenterol. 2004. PMID: 15128066 Review.

4

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease.

Sandborn WJ, Feagan BG, Fedorak RN, Scherl E, Fleisher MR, Katz S, Johanns J, Blank M, Rutgeerts P; Ustekinumab Crohn's Disease Study Group. Sandborn WJ, et al. Gastroenterology. 2008 Oct;135(4):1130-41. doi: 10.1053/j.gastro.2008.07.014. Epub 2008 Jul 17. Gastroenterology. 2008. PMID: 18706417 Clinical Trial.

5

Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission.

Clarke K, Regueiro M. Clarke K, et al. Inflamm Bowel Dis. 2012 Jan;18(1):174-9. doi: 10.1002/ibd.21792. Epub 2011 Jun 14. Inflamm Bowel Dis. 2012. PMID: 21674731 Review.

6

Abdominal pain in ulcerative colitis.

Coates MD, Lahoti M, Binion DG, Szigethy EM, Regueiro MD, Bielefeldt K. Coates MD, et al. Among authors: regueiro md. Inflamm Bowel Dis. 2013 Sep;19(10):2207-14. doi: 10.1097/MIB.0b013e31829614c6. Inflamm Bowel Dis. 2013. PMID: 23929261 Free PMC article.

7

Association between telephone activity and features of patients with inflammatory bowel disease.

Ramos-Rivers C, Regueiro M, Vargas EJ, Szigethy E, Schoen RE, Dunn M, Watson AR, Schwartz M, Swoger J, Baidoo L, Barrie A, Dudekula A, Youk AO, Binion DG. Ramos-Rivers C, et al. Clin Gastroenterol Hepatol. 2014 Jun;12(6):986-94.e1. doi: 10.1016/j.cgh.2013.11.015. Epub 2013 Nov 19. Clin Gastroenterol Hepatol. 2014. PMID: 24262938 Free PMC article.

8

The inflammatory bowel disease live interinstitutional and interdisciplinary videoconference education (IBD LIVE) series.

Regueiro MD, Greer JB, Binion DG, Schraut WH, Goyal A, Keljo DJ, Cross RK, Williams ED, Herfarth HH, Siegel CA, Oikonomou I, Brand MH, Hartman DJ, Tublin ME, Davis PL, Baidoo L, Szigethy E, Watson AR; IBD LIVE Physician Group. Regueiro MD, et al. Inflamm Bowel Dis. 2014 Oct;20(10):1687-95. doi: 10.1097/MIB.0000000000000187. Inflamm Bowel Dis. 2014. PMID: 25167213

9

Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement.

Schwartz DA, Ghazi LJ, Regueiro M, Fichera A, Zoccali M, Ong EM, Mortelé KJ; Crohn's & Colitis Foundation of America, Inc. Schwartz DA, et al. Inflamm Bowel Dis. 2015 Apr;21(4):723-30. doi: 10.1097/MIB.0000000000000315. Inflamm Bowel Dis. 2015. PMID: 25751066 No abstract available.

10

Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials.

Schwartz DA, Ghazi LJ, Regueiro M. Schwartz DA, et al. Inflamm Bowel Dis. 2015 Apr;21(4):737-52. doi: 10.1097/MIB.0000000000000377. Inflamm Bowel Dis. 2015. PMID: 25751068 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page